BioNxt Solutions Inc. (CVE:BNXT) | Finanzwire

Basculer en Français

10619	Companies
225690	Keywords
154256	Articles
119426	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 06/23/2026 at 23:25, 1 hour 44 minutes ago

BioNxt Solutions Completes $2M Non-brokered Private Placement

Private Placement Securities Warrants Investments BioNxt Solutions
PRESS RELEASE

published on 06/23/2026 at 23:20, 1 hour 49 minutes ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
BioNxt Solutions Inc. closes non-brokered private placement of units, plans to use proceeds for research and operations in Europe. Company updates on unsecured convertible debentures extension

Private Placement BioNxt Solutions Inc. Debt Extension European Research Bioscience Innovator
BRIEF

published on 06/15/2026 at 09:50, 8 days 15 hours ago

BioNxt Advances Commercialization for Patented Multiple Sclerosis Treatment

Business Development Multiple Sclerosis Cladribine BioNxt Solutions BNT23001
PRESS RELEASE

published on 06/15/2026 at 09:45, 8 days 15 hours ago

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF
BioNxt Solutions Inc. partners with a BD&L advisor to commercialize BNT23001, a sublingual Cladribine ODF for MS. Preparing for a human bioavailability study

BioNxt Solutions Inc. Commercialization BNT23001 Bioavailability Study BD&L Advisor
BRIEF

published on 06/12/2026 at 23:20, 11 days 1 hour ago

BioNxt Solutions Inc. Announces Private Placement Initiative

Private Placement Stock Warrants BioNxt Solutions R&D Funding European Operations
PRESS RELEASE

published on 06/12/2026 at 23:15, 11 days 1 hour ago

BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
BioNxt Solutions Inc. announces non-brokered private placement of units at $0.33 per Unit with maximum gross proceeds of $2,000,000. Offering includes common shares and purchase warrants

Private Placement Common Shares BioNxt Solutions Inc. LIFE Offering Purchase Warrants
BRIEF

published on 06/11/2026 at 00:35, 13 days ago

BioNxt Solutions Inc. Extends Convertible Debentures and Issues Warrants

Warrants Convertible Debentures Regulatory Approval Securities Legislation BioNxt Solutions
PRESS RELEASE

published on 06/11/2026 at 00:30, 13 days ago

BioNxt Solutions Inc. Announces Extension of Convertible Debentures and Issuance of Warrants
BioNxt Solutions Inc. announces amendment of terms for unsecured convertible debentures, extending maturity dates and issuing common share purchase warrants. For further details, visit bionxt.com

BioNxt Solutions Inc. Common Share Purchase Warrants Regulatory Approvals Debentures Maturity Dates
BRIEF

published on 05/19/2026 at 09:10, 1 month 4 days ago

BioNxt Progresses in Semaglutide Oral Dissolvable Film Development

Pharmaceutical Development BioNxt Solutions GLP-1 Therapies Sublingual Drug Delivery Semaglutide ODF
PRESS RELEASE

published on 05/19/2026 at 09:05, 1 month 4 days ago

BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development
BioNxt Solutions Inc. announces advancement of Semaglutide oral dissolvable film program into active pharmaceutical development phase, targeting growing GLP-1 market. Company leverages expertise in drug delivery systems for chronic diseases

BioNxt Solutions Inc. Oral Dissolvable Film Drug Delivery Systems Semaglutide GLP-1 Market

Accesswire

Published on 06/24/2026 at 00:00, 1 hour 9 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 1 hour 24 minutes ago

Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 1 hour 49 minutes ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 1 hour 54 minutes ago

EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/23/2026 at 23:00, 2 hours 9 minutes ago

International Battery Metals Ltd. Announces RSU Grant

View all ACCESSWIRE

EQS Group

Published on 06/23/2026 at 22:20, 2 hours 49 minutes ago

Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 4 hours 54 minutes ago

EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:59, 6 hours 10 minutes ago

Holding(s) in Company
Published on 06/23/2026 at 17:55, 7 hours 14 minutes ago

ABO Energy ABO Energy drives strategic development and future financing solution forward
Published on 06/23/2026 at 17:53, 7 hours 15 minutes ago

LIGHTON: LightOn confirms the total amount of its bond financing

Les Echos

Published on 06/23/2026 at 19:47, 5 hours 21 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 5 hours 59 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 16:47, 8 hours 22 minutes ago

Statement of transactions in own shares from June 15, 2026 to June 19, 2026
Published on 06/23/2026 at 15:44, 9 hours 25 minutes ago

Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 11 hours 9 minutes ago

Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada

View all LES ECHOS COMFI WIRE